Europe (WHO region) vs Iceland: Hypertension effective treatment coverage (controlled hypertension)
Europe (WHO region)
26.1%
in 2019
Iceland
51.8%
in 2019
Europe (WHO region) rank
3rd
Iceland rank
3rd
Hypertension effective treatment coverage (controlled hypertension) over time
- Europe (WHO region)
- Iceland
How they compare
Iceland currently reports 51.8% against 26.1% in Europe (WHO region), a difference of 25.7%.
That makes Iceland's figure about 2.0 times Europe (WHO region)'s.
Across all 30 years both countries report, Iceland has been ahead every year.
Europe (WHO region) ranks 3rd and Iceland ranks 3rd of 11 groups.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 6.4% | 15.0% | 8.6% | Iceland |
| 2000s | 14.4% | 31.7% | 17.3% | Iceland |
| 2010s | 23.4% | 47.9% | 24.5% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Europe (WHO region) or Iceland?
- Iceland, at 51.8% against 26.1% in Europe (WHO region) as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Europe (WHO region) and Iceland?
- 25.7%, with Iceland ahead.
- How many years of comparable data are there for Europe (WHO region) and Iceland?
- 30 years are reported by both, from 1990 to 2019.
- How do Europe (WHO region) and Iceland rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Europe (WHO region) ranks 3rd and Iceland ranks 3rd of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.